Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Oncology Institute Inc’s stock clocked out at $3.69, up 1.93% from its previous closing price of $3.62. In other words, the price has increased by $1.93 from its previous closing price. On the day, 1.64 million shares were traded. TOI stock price reached its highest trading level at $3.815 during the session, while it also had its lowest trading level at $3.57.
Ratios:
To gain a deeper understanding of TOI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.59 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 20.18 whereas as Long-Term Debt/Eq ratio is at 18.83.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on July 23, 2025, initiated with a Outperform rating and assigned the stock a target price of $8.
On July 16, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $6.
On May 15, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $7.BTIG Research initiated its Buy rating on May 15, 2025, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 05 ’25 when M33 Growth I L.P. sold 673,676 shares for $3.05 per share. The transaction valued at 2,054,712 led to the insider holds 13,950,557 shares of the business.
M33 Growth I L.P. sold 76,324 shares of TOI for $232,788 on Jun 05 ’25. The Director now owns 1,272,724 shares after completing the transaction at $3.05 per share. On Jun 03 ’25, another insider, Hively Brad, who serves as the Director of the company, sold 1,976,137 shares for $2.87 each. As a result, the insider received 5,672,106 and left with 603,501 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 339161536 and an Enterprise Value of 391931872. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 64.74. Its current Enterprise Value per Revenue stands at 0.972 whereas that against EBITDA is -8.619.
Stock Price History:
The Beta on a monthly basis for TOI is 0.13, which has changed by 5.7090907 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, TOI has reached a high of $4.03, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 27.59%, while the 200-Day Moving Average is calculated to be 161.63%.
Shares Statistics:
It appears that TOI traded 2.03M shares on average per day over the past three months and 2109380 shares per day over the past ten days. A total of 88.93M shares are outstanding, with a floating share count of 45.53M. Insiders hold about 50.46% of the company’s shares, while institutions hold 14.71% stake in the company. Shares short for TOI as of 1752537600 were 7145146 with a Short Ratio of 3.52, compared to 1749772800 on 2405246. Therefore, it implies a Short% of Shares Outstanding of 7145146 and a Short% of Float of 9.520000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
